Brainomix logo — AI-Enabled Precision Medicine

Brainomix

AI-Enabled Precision Medicine

Founded 2010 United Kingdom Oxford, United Kingdom 71 employees Series C Total: $42.85M AI, Biotechnology +2

General Information

Company Name Brainomix
Founded Year 2010
Location United Kingdom Oxford, United Kingdom +2
Employees 71
Industries AI, Biotechnology, Medical Devices +1
Funding Stage Series C
Social

Get notified when Brainomix moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Brainomix

Brainomix is a UK-based biotechnology startup that focuses on AI Enabled Precision Medicine. Since its establishment as a spin-out from the University of Oxford in 2010, the company has been committed to creating AI-powered imaging biomarkers to enable precision medicine for better treatment decisions.

Their innovative AI-powered imaging biomarkers and software solutions have gained recognition through numerous awards, assisting physicians worldwide in making better, life-saving decisions. Their dedication to advancing the field of precision medicine has garnered the attention of investors, with the latest £400.00K grant investment from Innovate UK in 09 October 2023.

Brainomix's focus on leveraging AI to revolutionize medical treatment decisions presents an exciting opportunity for potential investors looking to support groundbreaking advancements in biotechnology and healthcare.

Taxonomy: AI-powered imaging biomarkers, Precision medicine, Medical imaging technology, Diagnostic software, Machine learning in healthcare, Treatment decision support, University spin-out, Healthcare innovation, Artificial intelligence in medicine

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Series C •••••• 5
Investor Investor
•••• ••••
20 Mar 2025
Grant •••••• 1
Investor
09 Oct 2023
Series B •••••• 4
Investor Investor
•••• ••••
16 Dec 2021
Venture Round •••••• 4
Investor Investor Investor
•••• ••••
03 Apr 2018
Series B •••••• 2
Investor Investor
17 Oct 2016

View All 8 Funding Rounds

Brainomix Alternatives & Competitors

Brainomix vs
QMENTA
QMENTA United States

Medical imaging software solutions that improve outcomes for research, and clinical trials

Debt Financing
45 employees
AI, Analytics
Brainomix vs

Using a combination of science and AI technology, we aim to improve the lives of patients with neuro...

Series A
11 employees
Enterprise Software, Health Care
Brainomix vs
Imageens
Imageens France

Building the future of clinical decision making in cardiovascular health with smart imaging biomarke...

Seed
5 employees
Medical Devices

FAQ About Brainomix

AI-Enabled Precision Medicine
Brainomix was founded in 2010.
Brainomix is headquartered in Oxford, United Kingdom.
Brainomix operates in the following industries: AI, Biotechnology, Medical Devices, Machine Learning.
Brainomix has approximately 71 employees.
Brainomix has completed 8 funding rounds, raising a total of $42.85M. The latest funding stage is Series C.
Top alternatives and competitors to Brainomix include QMENTA, Combinostics, Imageens, Magnetic Insight, Inc, FLUIDDA. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Brainomix and QMENTA are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Brainomix and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy